The article was written by Thomas AM Kramer. I will await the information you receive from medscape.
----- Original Message ----- From: "Allen Esterson" <[EMAIL PROTECTED]> To: "Teaching in the Psychological Sciences" <[EMAIL PROTECTED]> Sent: Monday, April 26, 2004 5:53 AM Subject: Re: Suicide / Antidepressant > On 26 April Bill Scott wrote: > > > Okay, Allen, you make me do my homework. > > Regarding the issues below, this is from Medscape: Go to one of Thomas AM > > Kramer's CME articles at medscape such as: > > http://www.medscape.com/viewarticle/420839 > > > > Then click on "disclosures" at the top of the page. You will find the > > following. > > > > Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for > > clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds > > consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. > > > > Now I am no longer just highly suspicious that he is well funded by the drug > > companies, I "am sure". Still, thanks for making me provide the evidence for > > my conjectures. > > > I checked http://www.medscape.com/viewarticle/420839 and found the > article: > > Antidepressant Response and Noradrenaline > Disclosures > > Thomas Kramer, MD > > > I then clicked "Disclosures" and found the following: > > 42nd Annual Scientific Meeting of the American Headache Society > Clinical Features and Guidelines > > Faculty and Disclosures > > Authors > Martin L. Korn, MD > Private Practice, New York City, NY > Disclosure: Martin L. Korn, MD, has disclosed that he has discussed the > unlabeled use of topiramate, gabapentin, lamotragine, and carbamazapine in > the treatment of bipolar disorder. > > Peter D. Kramer, MD > Clinical Professor, Department of Psychiatry and Human Behavior, Brown > University. > Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for > clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds > consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. > > Takuya Saito, MD, PhD > Assistant Professor, Department of Psychiatry, Albert Einstein College of > Medicine, Bronx, New York. > Disclosure: Takuya Saito, MD, has no significant financial interests to > disclose. > > > As three Authors are cited, and from the heading, it is evident that the > "Disclosures" are for the Meeting as a whole, not specifically for the > article "Strategies and Tactics in the Medication Management of > Depression" by Thomas Kramer, MD. > > If you look more closely at the Disclosure list it is evident an error has > occurred: > > Peter D. Kramer, MD > Clinical Professor, Department of Psychiatry and Human Behavior, Brown > University. > Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for > clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds > consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. > > It would appear that the author for whom the disclosure is being made is > Peter D. Kramer, Brown University, not Thomas A. M. Kramer, Northwestern > University, Chicago. It looks as if whoever is responsible for preparing > the disclosure list may have mistakenly written "Thomas Kramer" in the > disclosure statement beneath the name Peter D. Kramer, MD. > > That "Thomas Kramer" is the likely error (not, the author cited, Peter D. > Kramer) is suggested from the previous named author, Martin L. Korn, MD. > In the disclosure statement the name Martin L. Korn, MD is repeated in > full, unlike in the case of Peter D. Kramer. Evidently the full name of > the author is always given in the disclosure statement, whereas in that > beneath Peter D. Kramer the shortened name "Thomas Kramer" is given. My > guess is that whoever wrote the disclaimer statement for Peter D. Kramer > confused the author of the article "Antidepressant Response and > Noradrenaline" (Thomas Kramer) with Peter D. Kramer, and wrote the wrong > name under the latter's disclosure information. > > But I hope all will be revealed after I receive a response from the > Medscape site director, to whom I have sent an e-mail asking him to > clarify this anomaly. > > Allen Esterson > Former lecturer, Science Department > Southwark College, London > [EMAIL PROTECTED] > > http://www.human-nature.com/esterson/index.html > http://www.butterfliesandwheels.com/articleprint.php?num=10 > > --- > You are currently subscribed to tips as: [EMAIL PROTECTED] > To unsubscribe send a blank email to [EMAIL PROTECTED] --- You are currently subscribed to tips as: [EMAIL PROTECTED] To unsubscribe send a blank email to [EMAIL PROTECTED]
